Outbreak of exogenous Fusarium endophthalmitis after cataract surgery was evaluated. Twenty patients developed postoperative endophthalmitis. In 19 eyes, pars plana vitrectomy (PPV) was performed, in 14 cases (74 %) with primary intraocular lens explantation. In one case, the PPV was not performed because of poor general condition of the patient. Symptoms of endophthalmitis (damaged vision, iritis, tyndallization in anterior chamber, hypopyon) occurred at intervals of 16-79 days (mean 31.3 days). Fungal etiology was documented in 12 eyes (60 %). Fusarium oxysporum was evidenced by culture and/or microscopy and confirmed by PCR and sequencing analysis. Eighteen (90 %) patients were treated with oral voriconazole (400 mg/day) for a period of 4-6 weeks. The final visual acuity was 6/15 in 1 case (5 %), 6/60 and worse in 17 eyes (85 %), and in 2 cases (10 %), enucleation had to be performed. Viscoelastic filling material was suggested the most likely source of infection. Endophthalmitis caused by Fusarium spp. are a potentially big threat for patients with serious impact on vision. Successful management of the infection is highly dependent on early diagnosis including species identification and antifungal susceptibility testing, and on aggressive and long-term treatment.

Department of Clinical Microbiology University Hospital and Charles University Medical Faculty Sokolska 581 500 05 Hradec Kralove Czech Republic

Zobrazit více v PubMed

Mycopathologia. 2006 Jan;161(1):43-52 PubMed

Ophthalmology. 1998 Mar;105(3):522-6 PubMed

J Antimicrob Chemother. 2008 Mar;61(3):616-20 PubMed

Ophthalmology. 2008 Sep;115(9):1501-7, 1507.e1-2 PubMed

Clin Microbiol Infect. 2009 Jul;15(7):634-42 PubMed

J Clin Microbiol. 2009 May;47(5):1463-8 PubMed

Arch Ophthalmol. 1980 Jun;98(6):1025-39 PubMed

Br J Ophthalmol. 2008 Jul;92(7):871-8 PubMed

Mycopathologia. 2006 Sep;162(3):245-53 PubMed

Am J Ophthalmol. 2004 May;137(5):820-5 PubMed

Pharmacogenomics. 2011 Jun;12(6):861-72 PubMed

Am J Ophthalmol. 2005 Sep;140(3):552-4 PubMed

Eur J Clin Microbiol Infect Dis. 2009 Jun;28(6):613-22 PubMed

Mycopathologia. 2012 Sep;174(3):233-7 PubMed

Clin Microbiol Rev. 2000 Oct;13(4):662-85 PubMed

Eye (Lond). 2008 Jan;22(1):13-7 PubMed

Cornea. 2003 May;22(4):300-3 PubMed

Antimicrob Agents Chemother. 2011 Nov;55(11):5150-4 PubMed

Infection. 2013 Feb;41(1):15-20 PubMed

Clin Microbiol Rev. 2003 Oct;16(4):730-97 PubMed

Mycopathologia. 2011 Jun;171(6):431-4 PubMed

Invest Ophthalmol Vis Sci. 2009 May;50(5):2230-6 PubMed

Cesk Oftalmol. 1988 Sep;44(5):362-8 PubMed

J Antimicrob Chemother. 2009 Oct;64(4):877-8 PubMed

Southeast Asian J Trop Med Public Health. 2012 Nov;43(6):1484-8 PubMed

Am J Ophthalmol. 2007 Feb;143(2):222-227 PubMed

Mycopathologia. 2010 Nov;170(5):291-313 PubMed

Clin Ophthalmol. 2010 Mar 24;4:121-35 PubMed

Clin Microbiol Rev. 2007 Oct;20(4):695-704 PubMed

Ocul Immunol Inflamm. 2000 Sep;8(3):189-200 PubMed

Curr Opin Ophthalmol. 2008 Jul;19(4):302-6 PubMed

J Hosp Infect. 1997 Jul;36(3):223-8 PubMed

Curr Eye Res. 2009 Nov;34(11):988-95 PubMed

Eye Contact Lens. 2012 Sep;38(5):331-5 PubMed

Am J Ophthalmol. 2001 Nov;132(5):609-17 PubMed

Cornea. 2013 May;32(5):667-73 PubMed

Diagn Microbiol Infect Dis. 2008 Nov;62(3):348-50 PubMed

J Ocul Pharmacol Ther. 2006 Dec;22(6):437-9 PubMed

Br J Ophthalmol. 2002 Jul;86(7):829-30 PubMed

Mycoses. 2011 Nov;54(6):e767-74 PubMed

Arch Ophthalmol. 2007 Jun;125(6):789-93 PubMed

J Clin Microbiol. 2005 Oct;43(10):5372-5 PubMed